Literature DB >> 12475691

Paratesticular leiomyosarcoma in an elderly man.

Fatima Eslami Varzaneh1, Mohan Verghese, Barry M Shmookler.   

Abstract

Soft tissue tumors, both benign and malignant, of the testes are relatively uncommon. Primary leiomyosarcoma of the testis is rare, and its clinical behavior is difficult to predict. We report a case of paratesticular leiomyosarcoma in a 71-year-old man. Routine histologic examination and immunohistochemical staining were performed. The tumor was composed of interlacing fascicles of smooth muscle cells with marked nuclear pleomorphism and three to four mitoses per high power field, with few atypical mitoses. On the basis of the microscopic examination and immunohistochemical studies, the tumor was identified as a paratesticular leiomyosarcoma. The published studies on this entity are reviewed.

Entities:  

Mesh:

Year:  2002        PMID: 12475691     DOI: 10.1016/s0090-4295(02)02076-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Med Mol Morphol       Date:  2015-05-19       Impact factor: 2.309

2.  A rare cause of a scrotal mass: primary leiomyosarcoma of epididymis.

Authors:  Maher Mechri; Samir Ghozzi; Ramzi Khiari; Fethi Bougrine; Ammar Bouziani; Nawfel Benrais
Journal:  BMJ Case Rep       Date:  2009-02-26

3.  Leiomyosarcoma of the epididymis: 2 cases and review of the literature.

Authors:  Victor T H Yuen; Shane D Kirby; Young Chi Woo
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

4.  Management of spermatic cord tumors: a rare urologic malignancy.

Authors:  Dayron Rodríguez; Aria F Olumi
Journal:  Ther Adv Urol       Date:  2012-12

5.  Paratesticular sarcomas: A report of seven cases.

Authors:  Yaşar Unlü; Gülben Erdem Huq; Gülzade Ozyalvaçli; Mehmet Zengin; Sevim Baykal Koca; Uğur Yücetas; Erol Rüştü Bozkurt; Kemal Behzatoğlu
Journal:  Oncol Lett       Date:  2014-10-23       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.